Page last updated: 2024-08-21

phthalimidine and Leukemia, Myeloid, Acute

phthalimidine has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P; Tian, J; Yang, L; Yang, Y; Zhang, F; Zhang, H; Zhou, J1

Other Studies

2 other study(ies) available for phthalimidine and Leukemia, Myeloid, Acute

ArticleYear
3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
    Bioorganic chemistry, 2019, Volume: 86

    Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Cycle Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Palladium; Phthalimides; Structure-Activity Relationship; Transcription Factors; Tumor Cells, Cultured

2019
Phthalimide-Conjugated Ligands Promote Selective Protein Destabilization.
    Cancer discovery, 2015, Volume: 5, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Azepines; Cell Cycle Proteins; Humans; Leukemia, Myeloid, Acute; Ligands; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Proteasome Endopeptidase Complex; Transcription Factors; Triazoles; Ubiquitin-Protein Ligases

2015